SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-24-002427
Filing Date
2024-05-01
Accepted
2024-05-01 16:30:37
Documents
20
Period of Report
2024-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_050124.htm   iXBRL 8-K 25024
2 EXHIBIT 10.1 exh_101.htm EX-10.1 175428
3 EXHIBIT 10.2 exh_102.htm EX-10.2 87541
4 EXHIBIT 10.3 exh_103.htm EX-10.3 93010
5 GRAPHIC db_sig.jpg GRAPHIC 30577
6 GRAPHIC wr_sig.jpg GRAPHIC 29232
7 GRAPHIC rb_sig.jpg GRAPHIC 33706
8 GRAPHIC fp_sig.jpg GRAPHIC 31385
  Complete submission text file 0001171843-24-002427.txt   815579

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE apto-20240429.xsd EX-101.SCH 3009
10 XBRL LABEL FILE apto-20240429_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE apto-20240429_pre.xml EX-101.PRE 22355
23 EXTRACTED XBRL INSTANCE DOCUMENT f8k_050124_htm.xml XML 3707
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 24903520
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)